Advertisement

Topics

Interleukin Genetics, Inc. Company Profile

15:09 EDT 25th September 2018 | BioPortfolio

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The Company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. Interleukin Genetics’ flagship products include its proprietary PST® genetic risk panel for periodontal disease and tooth loss susceptibility sold through dentists, and the Inherent Health Weight Management Genetic Test that identifies the most effective diet and exercise program for an individual based on genetics. Interleukin Genetics is headquartered in Waltham, MA and operates an on-site, state-of-the-art DNA testing laboratory certified under the Clinical Laboratories Improvements Act (CLIA). For more information please visit www.ilgenetics.com.


News Articles [467 Associated News Articles listed on BioPortfolio]

Rheumatoid arthritis drug may reduce inflammation after stroke

The pro-inflammatory cytokine interleukin-1 plays a significant role in brain injury following ischemic stroke by inducing peripheral inflammatory mediators, such as interleukin-6. However, pre-clinic...

MND Scotland starts new trial of Interleukin-2 for ALS

MND Scotland has launched a new clinical trial to test the safety and effectiveness of Interleukin-2, which is used for...Read More... The post MND Scotland starts new trial of Interleukin-2 for ALS a...

Increased interleukin-37 associated with adult-onset Still's disease

Increased levels of interleukin-37 are positively correlated with disease activity in adult-onset Still’s disease, according to findings published in Arthritis Research and Therapy.“[Interleukin (...

Interleukin-6 (IL-6) Inhibitors Therapeutics Global Pipeline Analysis Report 2017 - Clinical ...

The study analyzed that the IL-6 inhibitors therapeutics pipeline comprises approximately 18 active drug candidates in different stages of development. Interleukin-6 inhibitors acts on the Read mo...

Global Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis Report 2017 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patents, Designations, Collaborations, and Ot...

5 Top Genetics Stocks to Watch

The genetics industry provides information that biotech, pharma and medical device companies need to continue making innovative products. Here's a look at a few top genetics stocks. The post 5 Top Ge...

New findings reveal potential role of interleukin-1 alpha in risk for heart attacks, strokes

XBiotech Inc. announced today the publication of findings that point toward a white blood cell-derived interleukin-1 alpha (IL-1⍺) as a cause of blood clots that could lead to heart attacks or strok...

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

After demonstrating in 2016 how its synthetic biology technology could produce new biologic drugs, San Diego’s Synthorx today revealed that its lead drug candidate is an improved version of interleu...

Drugs and Medications [16 Associated Drugs and Medications listed on BioPortfolio]

Elidel [Physicians Total Care, Inc.]

Elidel

Elidel [Novartis Pharmaceuticals Corporation]

Elidel   (pimecrolimus) Cream 1% FOR DERMATOLOGIC USE ONLYNOT FOR OPHTHALMIC USE Rx only Prescribing Information See WARNINGS, boxed WARNING c oncerning long-term safe

Elidel [Valeant Pharmaceuticals North America LLC]

Elidel (pimecrolimus) Cream 1%

Proleukin [Novartis Pharmaceuticals Corporation]

Proleukin

Mycophenolate mofetil [Endo Pharmaceuticals Inc]

PubMed Articles [1029 Associated PubMed Articles listed on BioPortfolio]

Effect of polymorphisms in IL-12B p40, IL-17A and IL-23 A/G genes on the response of psoriatic patients to narrow band UVB.

Genetics play an important role in the development of psoriasis. Moreover, inter- individual genetic differences have explained the varied response of psoriatic patients to different therapeutic modal...

Identification of fused pyrimidines as interleukin 17 secretion inhibitors.

Inhibiting the interleukin 17 pathway is of interest in a number of autoimmune diseases. Herein, 42 fused pyrimidines have been evaluated as interleukin 17 secretion inhibitors using a phenotypic assa...

Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men.

Previous studies have indicated an association between interleukin-18 and glucose. Interleukin-18 becomes active when cleaved by caspase-1, activated by the NLR family pyrin domain containing-3 inflam...

Low Interleukin-7 Receptor Messenger RNA Expression Is Independently Associated With Day 28 Mortality in Septic Shock Patients.

Septic shock is the primary cause of death in ICUs. A better comprehension of its pathophysiology, in particular, the immune alteration mechanisms, opened new therapeutic perspectives such as the reco...

Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure.

To test whether plasma interleukin-1 receptor antagonist or variants within the gene encoding for interleukin-1ra (IL1RN), or proteins involved in regulating interleukin-1β levels or interleukin-1β ...

Clinical Trials [942 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining interleukin-2 with interleukin-12 may kill more tumor cells....

Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Interleukin-12 may kill tumor cells by stopping blood flow to the tumor. Interleukin-2 and interleukin-1...

High Dose IL 2 and Entinostat in RCC

This is a multicenter, randomized, open label study of high dose interleukin 2 vs high dose interleukin 2 plus entinostat in treatment-naïve clear cell RCC patients who are candidate for ...

Interleukin-2 and Interleukin-12 in Treating Patients With Refractory or Advanced Solid Tumors

RATIONALE: Interleukin-2 may stimulate a person's lymphocytes to kill solid tumor cells. Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person...

Companies [44 Associated Companies listed on BioPortfolio]

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Globe Laboratories

Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to ...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

More Information about "Interleukin Genetics, Inc." on BioPortfolio

We have published hundreds of Interleukin Genetics, Inc. news stories on BioPortfolio along with dozens of Interleukin Genetics, Inc. Clinical Trials and PubMed Articles about Interleukin Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Interleukin Genetics, Inc. Companies in our database. You can also find out about relevant Interleukin Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record